309 related articles for article (PubMed ID: 17295394)
21. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.
Solé-Padullés C; Bartrés-Faz D; Junqué C; Vendrell P; Rami L; Clemente IC; Bosch B; Villar A; Bargalló N; Jurado MA; Barrios M; Molinuevo JL
Neurobiol Aging; 2009 Jul; 30(7):1114-24. PubMed ID: 18053618
[TBL] [Abstract][Full Text] [Related]
22. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
[TBL] [Abstract][Full Text] [Related]
23. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
24. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
25. Brain N-acetylaspartate is reduced in Parkinson disease with dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimer Dis Assoc Disord; 2008; 22(1):54-60. PubMed ID: 18317247
[TBL] [Abstract][Full Text] [Related]
26. Reduced hippocampal glutamate in Alzheimer disease.
Rupsingh R; Borrie M; Smith M; Wells JL; Bartha R
Neurobiol Aging; 2011 May; 32(5):802-10. PubMed ID: 19501936
[TBL] [Abstract][Full Text] [Related]
27. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
29. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
[TBL] [Abstract][Full Text] [Related]
30. Correlation of auditory event-related potentials and magnetic resonance spectroscopy measures in mild cognitive impairment.
Li X; Shao X; Wang N; Wang T; Chen G; Zhou H
Brain Res; 2010 Jul; 1346():204-12. PubMed ID: 20470761
[TBL] [Abstract][Full Text] [Related]
31. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268
[TBL] [Abstract][Full Text] [Related]
32. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
33. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
[TBL] [Abstract][Full Text] [Related]
34. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
Waldman AD; Rai GS
Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
[TBL] [Abstract][Full Text] [Related]
35. Treatment monitoring and response prediction with proton MR spectroscopy in AD.
Jessen F; Traeber F; Freymann K; Maier W; Schild HH; Block W
Neurology; 2006 Aug; 67(3):528-30. PubMed ID: 16894124
[TBL] [Abstract][Full Text] [Related]
36. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
[TBL] [Abstract][Full Text] [Related]
37. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
Tsai CF; Hung CW; Lirng JF; Wang SJ; Fuh JL
East Asian Arch Psychiatry; 2013 Sep; 23(3):86-90. PubMed ID: 24088401
[TBL] [Abstract][Full Text] [Related]
38. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
[TBL] [Abstract][Full Text] [Related]
39. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
[TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy in school-aged autistic children.
Vasconcelos MM; Brito AR; Domingues RC; da Cruz LC; Gasparetto EL; Werner J; Gonçalves JP
J Neuroimaging; 2008 Jul; 18(3):288-95. PubMed ID: 18304036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
